Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders - Wikidata - awgldk - TriplyDB

Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders

Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders

http://www.wikidata.org/entity/Q33998847

about

Anti-Aging Potential of Phytoextract Loaded-Pharmaceutical Creams for Human Skin Cell Longetivity Melasma: treatment strategy.S-(-)-10,11-dihydroxyfarnesoic acid methyl ester inhibits melanin synthesis in murine melanocyte cells.Topical tranexamic acid as a promising treatment for melasma An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy.Biochemical effects of the flavanol-rich lychee fruit extract on the melanin biosynthesis and reactive oxygen species.Skin photoprotection and consumption of coffee and polyphenols in healthy middle-aged Japanese females.Inhibitory effect of phthalic Acid on tyrosinase: the mixed-type inhibition and docking simulations Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575.Antioxidant and Tyrosinase Inhibitory Activities of Seed Oils from Fort. ex Lindl

P2860

Q26786015-95C56259-82E1-44E7-B905-BD0429062B26 Q34043685-F5D19CA3-DF5D-47E8-8CAD-DE6A12DEAC3A Q34072508-D25DF08F-8C56-41D1-817D-DF94111DEB62 Q34529832-F55D1AFC-E1E7-4756-BE47-21383AA7A2E3 Q37600489-67B5E3C9-80DF-4AD8-94E4-999B2D6E92C9 Q38786839-1183E1CB-A463-405E-B080-1D9662031A5F Q40208733-4515CEDE-4AB9-4B07-85F4-182FF561992E Q42739499-013035AB-BA7D-4DF5-B564-8BF5F0554D11 Q46508701-39C91663-7BEC-4891-8191-35A868B9CFD6 Q57493061-9EDEA142-428A-4A0B-BF3D-A4D468B1FA5A

P2860

Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders

http://www.wikidata.org/entity/Q33998847

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@ast

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@en

type

label

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@ast

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@en

prefLabel

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@ast

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@en

P1433

Q33998847-8F329366-D352-48DC-AF35-660375CE4DB4

P1476

Q33998847-A936AC6F-3E25-4ACB-BA5E-C7723ABBC87B

P2093

Q33998847-1B56A808-943F-4F00-BB2D-089BACA52F7B

Q33998847-4EF54319-FE17-410D-8F7F-A1DB95C189C8

Q33998847-F9833362-396B-4A0D-8A9E-47D726BA9048

P275

Q33998847-F348FBC2-81FE-40DA-933E-E528143B4B43

P2860

Q33998847-073B6A56-3EEC-46B1-822F-90F6B4D7FC0F

Q33998847-246C5B6E-7B5C-443D-9191-2380D8CDD4C3

Q33998847-36012673-B8C3-4FEE-852B-C5156BF208F6

Q33998847-3A56831F-42C7-444C-84D0-DFDE00B91BB9

Q33998847-3C8856DC-3F2A-4453-8213-7E3F2D68B4FA

Q33998847-3F8D199F-CC86-4438-A230-9E0667DB42FD

Q33998847-404B85C7-D6E4-4A1F-90C5-AFB6D1E954A7

Q33998847-4052ADCF-09DF-4B6D-9DFC-EA04AA9CC24D

Q33998847-452DDAF3-7B97-4204-B7EA-CC8AF0FD544D

Q33998847-4577F80D-895D-4247-B2B0-C4B1378FAD65

P304

Q33998847-7842869B-1F0B-4518-974A-B65AE5B0F121

P31

Q33998847-026C5CE7-899F-4EED-BA4A-A01562FAAC10

Q33998847-C510B1C7-240F-48FC-8A16-DC769F5D001C

P356

Q33998847-68CD7D03-137E-47DE-977B-321664C8A618

P407

Q33998847-9AA0E90F-1A72-47DF-934B-5A0964DF0C71

P433

Q33998847-0FE39DD2-7D2D-4936-B452-829F18DA1880

P478

Q33998847-27866DFB-6AE6-4798-9D05-A56C108B236B

P577

Q33998847-2F6E9E69-5BB1-49CF-B4D4-042437F4640A

P5875

Q33998847-85FAA1B2-B3E8-4921-86C5-878E68EF9885

P698

Q33998847-5D91F1D9-9A15-4707-B9DC-91DF62C06E22

P921

Q33998847-89E41A15-24C8-4F1A-9825-85642901E944

P932

Q33998847-5BA19C65-0E55-413F-BE56-3DA42A268C55

P356

P1433

International Journal of Molecular Sciences

P1476

Quasi-drugs developed in Japan ...... t of hyperpigmentary disorders

@en

P2093

Hideya Ando

http://www.w3.org/2001/XMLSchema#string

Mary S Matsui

http://www.w3.org/2001/XMLSchema#string

Masamitsu Ichihashi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Arbutin: mechanism of its depigmenting action in human melanocyte culture

Melanin pigmentation in mammalian skin and its hormonal regulation

Chemical and instrumental approaches to treat hyperpigmentation.

Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future.

Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase.

Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.

Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells

Tyrosinase maturation through the mammalian secretory pathway: bringing color to life.

Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.

The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.

P304

2566-2575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS11062566

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45272527

http://www.w3.org/2001/XMLSchema#string

P698

20640168

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

2904932

http://www.w3.org/2001/XMLSchema#string